Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FDJ10
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $148,348
Award facts
- Contract value 100% obligated
- $148,347.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $148,347.90 on April 24, 2025, for the supply of Entyvio 300 mg vials. The contract, issued by the Defense Logistics Agency (DLA), carries an ultimate completion date of May 15, 2025, and represents no set-aside designation. Entyvio is a biologic medication used in the treatment of inflammatory bowel disease conditions, and this delivery order fulfills pharmaceutical supply requirements for Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. The IDC, established under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to support military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent performance on DLA contracts covering an extensive portfolio of medications and medical products.
Quick answers
Who was awarded contract SPE2DB25FDJ10?
SPE2DB25FDJ10 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FDJ10 worth?
The government has obligated $148,348 on SPE2DB25FDJ10.
Is contract SPE2DB25FDJ10 an order under another contract?
Yes. SPE2DB25FDJ10 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDJ10 competed?
The extent of competition for SPE2DB25FDJ10 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award